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Laser beams can be used to induce biological stimulation, promote cell regeneration, improve blood circulation, diminish inflammation, relieve pain, and regulate immune functions (Zhu, 2003; Hashmi et al., 2010). Short wavelength laser beams (*e.g*., 650 nm) can be used to induce pathological changes in superficial tissues, while infrared laser beams (*e.g*., 810 nm) have a better penetration into the skin, fat and muscle tissues as well as bone tissues, and therefore can be used for the treatment of deep tissue lesions. The overall effect of different laser wavelength combinations can be used to obtain therapeutic efficacy in tissues of different depths.

Low-power laser therapy has been widely used for the physical treatment of orthopedics, wound surgery and pain diseases such as osseous pain, muscle pain, soft tissue pain, neuralgia, and trauma pain. However, there is a long-standing dispute regarding the efficacy of low-power laser therapy for some diseases. For example, in the conservative treatment of mild to moderate carpal tunnel syndrome (CTS), a common entrapment neuropathy involving the median nerve at the wrist (Phalen, 1966; Chen, 2008), using low-power laser beams to irradiate the wrist of patients was reported to be a simple and non-invasive physical therapy (Weintraub, 1997; Padua et al., 1998; Naeser et al., 2002; Bakhtiary and Rashidy-Pour, 2004; Naesera, 2006; Evcik et al., 2007; Piazzini et al., 2007; Rochkind et al., 2007a; Chang et al., 2008; Dincer et al., 2009; Bales and Meals, 2010;Tascioglu et al., 2012; Fusakul et al., 2014). However, the effects of laser treatment reported by different studies were different and often contradictory (Enwemeka et al., 2004; Irvine et al., 2004; Naesera, 2006; Piazzini et al., 2007; Rochkind et al., 2007b; Shooshtari et al., 2008; Yagci, 2009; Wu and Yu, 2010; Casale et al., 2013). Piazzini et al. (2007) systematically reviewed all published results (based on MEDLINE database) regarding the laser therapy of CTS (confirmed by clinical symptoms and electrophysiological tests) between January 1985 and May 2006 and reported that the conclusions regarding the efficacy of laser therapy of CTS were highly inconsistent.

Laser parameters in low-power laser irradiation therapy, including the laser power onto the action point, irradiation area, time duration of laser action, time interval between each laser action, and especially the optical power and power density at therapeutic targets, are closely related to the laser effect on human tissues (van Breugel and Bar, 1992; Bjordal et al., 2003; Zhu, 2003). To evaluate the efficacy of low-power laser therapy, laser parameters should be accurately measured and controlled, which were ignored in most previous clinical trials (Bjordal et al., 2003).

Naesera (2006) reviewed seven CTS cases undergoing laser therapy and found that the total laser irradiation doses (9 J, 12--30 J, 32 J/cm^2^, and 225 J/cm^2^) in five cases where the positive effect of laser treatment was concluded were significantly higher than in those of two cases where a negative effect was concluded (1.8 J or 6 J/cm^2^). However, in the five cases showing a positive effect, there were large variations from case to case regarding the laser parameters. For example, the laser wavelength in these cases was single or a combination of 830-nm, 632.8-nm, 904-nm, and 670-nm laser beams. The laser energy density, time duration of each laser action, and the time interval between laser actions also differed for different cases.

Does a higher laser power or a higher laser energy density always lead to a positive result of laser therapy for CTS? The answer is no. In 2007, Bjordal (2007) reported that high laser energy and energy density in laser therapy for CTS may lead to unfavorable factors.

In recent studies using a combination of 1,064 nm + 830-nm double wavelength laser beams (Casale et al., 2013), the authors claimed that an obvious curative effect was achieved because the long-wavelength laser beam penetrated deeper and scattered less. However, the laser power used for the treatment was as high as 25 W, which is two orders of magnitude higher than that of the hundreds of mW generally used for low-power laser therapy. Consequently, it is unclear whether the high-laser power or the long wavelength mediated the positive effect of the laser treatment.

What is the best laser parameter for CTS therapy? Are there thresholds for laser power, energy density, and total irradiation laser energy? In a clinical trial of lower-power laser therapy, usually only the output laser power from the laser head is recorded or adjusted. Based on standard formulas, some studies took into account the scattering loss inside human tissues before arriving at the action target; however, no individual difference was considered. To the best of our knowledge, previous clinical trials of CTS therapy never monitored the actual laser parameters at the skin of the wrist.

When a laser beam irradiates human skin, significant reflection and scattering occur (Xie et al., 2003; Michel et al., 2013), which leads to a lower effective laser power compared with that from the laser head. There were no measurements of the effective laser power at the wrist of patients in previous studies of laser therapy for CTS. In addition, clinical studies have shown that the laser reflection and scattering of human skin show significant individual differences (Xie et al., 2003). Therefore, it is necessary to measure the effective laser power for every patient receiving low-power laser therapy to compare and evaluate the efficacy of laser therapy.

To solve these existing problems in the low-power laser therapy for CTS, we proposed and developed a device to monitor quantitatively the effective laser power into the wrist skin of CTS patients to control quantitatively the laser parameters in clinical laser therapy. By monitoring the laser backside reflection and scattering signal, we obtained the effective laser power at the skin surface of a patient's wrist. This device is expected to become useful auxiliary equipment for monitoring effective laser parameters in many clinical applications using low-power laser therapy.

Subjects and Methods {#sec1-2}
====================

Subjects {#sec2-1}
--------

By using the detection head coupled with a commercial laser therapeutic apparatus (Diode Laser System for Pain MDC-500-I, nominal output laser power: 0--500 mW, laser wavelength: 810 ± 20 nm; Shanghai Mandisen Optoelectronics Co., Ltd., Shanghai, China), we investigated the effective laser power for 30 CTS patients during laser therapy. The enrolled patients with mild to moderate CTS were treated in the Department of Neurology at Shanghai Tongji Hospital, Shanghai, China from January 2013 to May 2014. The 30 (26 females) enrolled patients had a mean age of 54.2 years (range 35--70 years).

Inclusion criteria: (1) mild to moderate CTS diagnosed according to the literature (Gu, 2005, 2011); (2) no tumor or infectious diseases; (3) no photosensitivity reaction; (4) no serious heart, liver or kidney diseases; and (5) no other peripheral neuropathy.

Exclusion criteria: (1) acute wrist trauma and surgery; (2) treated with other methods; and (3) pregnancy.

This clinical research was approved by the Ethics Committee of Shanghai Tongji Hospital and all patients received laser therapy after providing informed consent.

Schematic of effective laser power measurement {#sec2-2}
----------------------------------------------

The schematic for measuring the backside reflection and scattering of the laser beam in the full hemisphere is shown in **[Figure 1](#F1){ref-type="fig"}**. The backside reflection and scattering from the surface (skin) were assumed to be axial symmetric; therefore, the measurement can be achieved in the plane of incidence, which is then integrated to obtain data for the full hemisphere. Sixteen photodiodes (S2386-18K Pin diode, Hamamatsu Co., Ltd., Hamamatsu, Japan) were uniformly arranged around a circle on the two sides of the laser head. Four more were used for calibration. In the calibration, filtering, fitting, and weighted operations were performed to ensure the measurement accurately accounted for the backside reflection and scattering in the full hemisphere.

![Schematic of the backside reflection and scattering measurement from the surface of wrist skin.\
The arrow indicates the propagation direction of the laser beam. The backside reflection and scattering from the surface (skin) are assumed to be axial symmetric and therefore measurements can be performed with 16 photodiodes uniformly arranged around a circle in the incidence plane on the two sides of the laser head, which is then integrated to obtain data of the full hemisphere.](NRR-11-1180-g002){#F1}

Device for effective laser power measurement {#sec2-3}
--------------------------------------------

We developed a device composed of three main parts: a detection head, a data collector, and a computer with control software. The structure of the detection head is shown in **[Figure 2](#F2){ref-type="fig"}**. The detection head is directly fixed to the existing laser head of the commercial laser therapy apparatus and the Hamamatsu S2386-18k Pin diode is used as the detector. The signal current from the Pin diode is converted to a 0 to 10-V signal in the pre-amplifier circuit to facilitate subsequent data collection and analysis. The detection head size is 172 × 62 × 40 mm^3^, which fits well with the laser head of the commercial laser therapy apparatus (Diode Laser System for Pain MDC-500-I, Shanghai Mandisen Optoelectronics Co., Ltd.).

![Structure of the detection head with the laser head installed.\
The detection head (172 × 62 × 40 mm^3^) is directly fixed to the existing laser head of the commercial laser therapy apparatus and the Hamamatsu S2386-18k Pin diode is used as the detector. The preamplifier printed circuit board (PCB) converted the signal current from Pin diodes to voltage signal to facilitate subsequent data collection and analysis.](NRR-11-1180-g003){#F2}

Data acquisition and procession {#sec2-4}
-------------------------------

The data collector includes a USB data acquisition card (NI USB-6210) and its power supply. The USB acquisition card converts the analog signals collected by the 16 Pin Diodes into digital signals, and transmits data to the computer through the USB port, where data processing is performed.

Software interface {#sec2-5}
------------------

To enhance the practical experience and make operation easy during clinical applications, a good user interface is an indispensable part of the device. We developed the software for this device by adopting LabVIEW programming software, with the help of a graphical programming environment and intuitive icons and wires. The software provides functions including data collection, data processing, data storage, and reading modules. The data storage and reading modules help to catalog different kinds of information (including the reflection and scattering power at different angles in the incidence plane shown in **[Figure 1](#F1){ref-type="fig"}**), which is convenient for the follow-up of patients and historical data processing.

Device calibration {#sec2-6}
------------------

First, the device should be fully calibrated to acquire the correct backside reflecting and scattering laser power values. All the Pin detectors should be calibrated to the same sensitivity and magnification factor. According to the existing conditions, we put all the detectors on the same status and exposed them to sunlight, which can be considered a uniform parallel light source. The voltage signals from all 16 Pin detectors were then adjusted to the same value to complete the first calibration step. Then, the final data value through integral processing represents the relative value of backside reflecting and scattering laser power. To obtain the absolute value, the next calibration process is divided into two steps, as shown in **[Figure 3](#F3){ref-type="fig"}**. First, the laser head of the therapy apparatus is used to irradiate a piece of ground glass, and behind the ground glass, we placed an optical power meter to record the total power of the transmitted light. Second, the optical power meter is replaced by the detection head. Thus, the corresponding relationship between the signal from the detection head and the absolute value of the reflecting and scattering laser power was obtained.

![Relationship between the signal from the detection head and the absolute value of reflecting and scattering laser power.\
Step 1: The laser head of the therapy apparatus is used to irradiate a piece of ground glass, and an optical power meter is placed behind the ground glass to record the total power of transmitted light. Step 2: The optical power meter is replaced by the detection head. The relationship between the signal from the detection head and the absolute value of reflecting and scattering laser power can be calculated.](NRR-11-1180-g004){#F3}

Results {#sec1-3}
=======

We observed a significant inter-individual difference between CTS patients. We defined the ratio between the measured reflection and scattering laser power in the backside hemisphere to the output power from the laser head as the reflection coefficient. The measured laser reflection coefficient from CTS patient wrists varied from 1.8% to 54%, as shown in **[Figure 4](#F4){ref-type="fig"}**. We calculated the patient numbers in different ranges of the measured reflection coefficients (\<10%, 10--20%, 20--30%, 30--40%, 40--50%, and 50--60%), and obtained the probability distribution of wrist reflection coefficients using the ratios between patient numbers in different ranges and the total patient number of 30. **[Figure 5](#F5){ref-type="fig"}** shows the probability distribution of wrist reflection coefficients for 30 cases. The reflection coefficient for 36.7% of the 30 cases was in the range of 10--20%, while that of 16.7% cases was higher than 40%.

![Measured wrist reflection coefficient for 30 carpal tunnel syndrome patients.\
We defined the ratio between the measured reflection and scattering laser power of wrist skin in the backside hemisphere to the output power from the laser head as the reflection coefficient. The measured laser reflection coefficient from the wrists varies from 1.8% to 54%.](NRR-11-1180-g005){#F4}

![Probability distribution of the measured wrist reflection coefficients for 30 carpal tunnel syndrome patients.\
The reflection coefficient for 36.7% of the 30 cases is in the range of 10--20%, while in 16.7% of cases, it is higher than 40%](NRR-11-1180-g006){#F5}

Discussion {#sec1-4}
==========

The clinical measurements obtained in this study clearly indicate the inter-individual differences between CTS patients, but also that the effective laser power at the wrist skin is significantly lower than at the laser head. Additional optical power loss during the propagation of laser beams from the skin to the median nerve at the wrist should be taken into account to determine the laser power at therapeutic targets. Analysis of the optical penetration depth and scattering in human tissues has been reported (Xie et al., 2003; Michel et al., 2013). Further measurement and modeling should be conducted to understand the individual differences found in this study.

This clinical trial shows that the proposed and developed device for monitoring the effective laser power for CTS therapy is necessary and feasible. Further investigation should be performed to determine the relationship between effective laser power and efficacy of laser therapy for CTS. Once the actual laser power at the wrist skin can be measured, it will be possible to determine the appropriate laser parameter range for individual CTS therapy and therefore to clarify the discrepancy in the literature.

In conclusion, we report the first measurement of effective optical power during laser therapy of CTS by monitoring the backside reflection and scattering laser power from the skin of human wrists. Using clinical measurements from 30 CTS cases, we found that the effective laser power differed significantly between patients, with a measured laser reflection coefficient ranging from 1.8% to 54%. Consequently, monitoring of the effective optical power during laser therapy will help clarify the dispute on the efficacy of laser therapy for CTS. Furthermore, this developed method and device might be useful for other lower-power laser therapies.
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